MiMedx Group MDXG Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $48.58M+15.7% | $42M-37.7% | $67.44M+323% | -$30.2M— | ||
| $16.4M-3.2% | $16.93M+1.2% | $16.74M+47.8% | $11.33M-20.0% | ||
| -$8.71M+30.2% | -$12.47M-133% | $37.8M— | $0— | ||
| $6.52M+997% | $594K-59.0% | $1.45M-44.2% | $2.6M— | ||
| $26.39M+934% | $2.55M-79.1% | $12.24M+106% | $5.94M-47.6% | ||
| —— | —— | $7.84M— | —— | ||
| —— | —— | $783K— | —— | ||
| —— | —— | —— | $2.37M+112% | ||
| $8.82M— | —— | —— | —— | ||
| $289K— | —— | —— | —— | ||
| $641K— | —— | —— | $542K— | ||
| $1.26M-3.7% | $1.31M+3.3% | $1.27M+0.7% | $1.26M+27.3% | ||
| $74M+11.8% | $66.2M+147% | $26.78M+242% | -$18.85M— | ||
| $1.03M-38.6% | $1.68M-15.3% | $1.99M+31.2% | $1.51M-53.0% | ||
| $3.76M-52.1% | $7.86M— | $0— | $0— | ||
| -$6.89M+29.0% | -$9.7M-350% | -$2.16M+19.0% | -$2.66M+21.6% | ||
| $3.12M+18.1% | $2.64M— | $0— | —— | ||
| -$5.41M+84.2% | -$34.23M-299% | -$8.57M— | —— | ||
| $61.71M+175% | $22.42M+39.7% | $16.05M+173% | -$21.85M— | ||
| -$8.71M+30.2% | -$12.47M-133% | $37.8M— | $0— | ||
| $8.99M+210% | $2.9M+49.9% | $1.93M+195% | -$2.04M— | ||
| $8.82M— | —— | —— | —— | ||
| $1.26M-3.7% | $1.31M+3.3% | $1.27M+0.7% | $1.26M+27.3% | ||
| $6.52M+997% | $594K-59.0% | $1.45M-44.2% | $2.6M— | ||
| $2.09M+5,397% | $38K-77.4% | $168K-85.3% | $1.15M— | ||
| $3.76M-52.1% | $7.86M— | $0— | $0— | ||
| $1.03M-38.6% | $1.68M-15.3% | $1.99M+31.2% | $1.51M-53.0% | ||
| $0+100% | -$57K-9.6% | -$52K-26.8% | -$41K— | ||
| —— | —— | —— | —— | ||
| $1.29M+1,518% | $80K— | $0— | —— | ||
| —— | —— | $168K-1.2% | $170K-32.5% | ||
| $1M0.0% | $1M— | $0— | $0— | ||
| $72.97M+13.1% | $64.52M+160% | $24.79M+224% | -$20.02M— | ||
| $72.97M+13.1% | $64.52M+160% | $24.79M+224% | -$20.02M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does MiMedx Group generate?
- MiMedx Group (MDXG) generated $70.6M in operating cash flow over the trailing twelve months.
- What is MiMedx Group's free cash flow?
- After $1.2M of capital expenditures, MiMedx Group's free cash flow was $69.4M over the trailing twelve months, up 7.4% year over year.
- Where does MiMedx Group's cash flow data come from?
- Every line is extracted from MiMedx Group's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
